Genetic diversity of transmission-blocking vaccine candidates Pvs25 and Pvs28 in Plasmodium vivax isolates from Yunnan Province, China

Parasites and Vectors

Volumn 4, Issue 1, 2011, Pages

  Feng, Hui ^a   Zheng, Li ^a   Zhu, Xiaotong ^a   Wang, Gege ^a   Pan, Yanyan ^a   Li, Ying ^a   Yang, Yimei ^b   Lin, Yahui ^c   Cui, Liwang ^d   Cao, Yaming ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b Dali Medical College   (China)

^c INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^d PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Plasmodium vivax; polymorphism; Pvs25; Pvs28; TBVs

Indexed keywords

DNA; EPIDERMAL GROWTH FACTOR; GENOMIC DNA; GLYCOSYLPHOSPHATIDYLINOSITOL; MALARIA VACCINE; PARASITE ANTIGEN; RECOMBINANT PROTEIN; RECOMBINANT PVS25 PROTEIN; RECOMBINANT PVS28 PROTEIN; TRANSMISSION BLOCKING VACCINE; UNCLASSIFIED DRUG; MEMBRANE ANTIGEN; PROTOZOAL DNA; PVS25 PROTEIN, P VIVAX; PVS28 PROTEIN, P VIVAX;

AMINO ACID SUBSTITUTION; ARTICLE; BLOOD; CHINA; DISEASE TRANSMISSION; ENDEMIC DISEASE; GENE; GENETIC ANALYSIS; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; HAPLOTYPE; IMMUNOGENICITY; MALARIA; MALARIA CONTROL; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PARASITE DEVELOPMENT; PARASITE ISOLATION; PLASMODIUM VIVAX; POLYMERASE CHAIN REACTION; PROTEIN DOMAIN; PVS25 GENE; PVS28 GENE; CHEMISTRY; CLASSIFICATION; DNA SEQUENCE; GENETICS; HUMAN; HUMAN EXPERIMENT; ISOLATION AND PURIFICATION; MOLECULAR GENETICS; PARASITOLOGY; PLASMODIUM VIVAX MALARIA;

PLASMODIUM VIVAX;

AMINO ACID SUBSTITUTION; ANTIGENS, PROTOZOAN; ANTIGENS, SURFACE; CHINA; DNA, PROTOZOAN; GENETIC VARIATION; HAPLOTYPES; HUMAN EXPERIMENTATION; HUMANS; MALARIA VACCINES; MALARIA, VIVAX; MOLECULAR SEQUENCE DATA; PLASMODIUM VIVAX; SEQUENCE ANALYSIS, DNA;

EID: 84855336170     PISSN: None     EISSN: 17563305     Source Type: Journal    
DOI: 10.1186/1756-3305-4-224     Document Type: Article

References (37)

1. World malaria report 2009. World Health Organization, Geneva 2009
2. The neglected burden of Plasmodium vivax malaria. Mendis K, Sina BJ, Marchesini P, Carter R, Am J Trop Med Hyg 2001 64 97 106 11425182 (Pubitemid 32552576)
3. Malaria situation in the People's Republic Of China in 2009. Zhou SS, Wang Y, Xia ZG, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 2011 29 1 3 21823314
4. China to eliminate Malaria Action Plan (2010-2020). Ministry of Health of the People's Republic of China, 2010
5. Malaria in the Greater Mekong Subregion: Heterogeneity and complexity. Cui L, Yan G, Sattabongkot J, Cao Y, Chen B, Chen X, Fan Q, Fang Q, Jongwutiwes S, Parker D, Sirichaisinthop J, Kyaw MP, Su XZ, Yang H, Yang Z, Wang B, Xu J, Zheng B, Zhong D, Zhou G, Acta Trop 2011
6. Space-time variation of malaria incidence in Yunnan province, China. Clements AC, Barnett AG, Cheng ZW, Snow RW, Zhou HN, Malar J 2009 8 180 10.1186/1475-2875-8-180 19646240
7. [Malaria situation in the People's Republic of China in 2006]. Zhou SS, Wang Y, Tang LH, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 2007 25 439 441 18441886
8. [Malaria situation in the People's Republic Of China in 2007]. Zhou SS, Wang Y, Fang W, Tang LH, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 2008 26 401 403 19288908
9. [Malaria situation in the People's Republic of China in 2008]. Zhou SS, Wang Y, Fang W, Tang LH, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 2009 27 457 455-456 20232622
10. Spatial and temporal distribution of falciparum malaria in China. Lin H, Lu L, Tian L, Zhou S, Wu H, Bi Y, Ho SC, Liu Q, Malar J 2009 8 130 10.1186/1475-2875-8-130 19523209
11. Transmission blocking vaccines. Kaslow DC, Malaria Vaccine Development ASM books, Hofman SL, 1996 181 228
12. Transmission-blocking vaccine of vivax malaria. Tsuboi T, Tachibana M, Kaneko O, Torii M, Parasitol Int 2003 52 1 11 10.1016/S1383-5769(02)00037-5 12543142 (Pubitemid 36110516)
13. P25 and P28 proteins of the malaria ookinete surface have multiple and partially redundant functions. Tomas AM, Margos G, Dimopoulos G, van Lin LH, de Koning-Ward TF, Sinha R, Lupetti P, Beetsma AL, Rodriguez MC, Karras M, Hager A, Mendoza J, Butcher GA, Kafatos F, Janse CJ, Waters AP, Sinden RE, EMBO J 2001 20 3975 3983 10.1093/emboj/20.15.3975 11483501 (Pubitemid 32751814)
14. Blocking effect of a monoclonal antibody against recombinant Pvs25 on sporozoite development in Anopheles sinensis. Moon SU, Kim HH, Kim TS, Choi KM, Oh CM, Ahn YJ, Hwang SK, Sohn Y, Shin EH, Kim H, Lee HW, Clin Vaccine Immunol 2010 17 1183 1187 10.1128/CVI.00101-10 20554802
15. Blocking of transmission to mosquitoes by antibody to Plasmodium vivax malaria vaccine candidates Pvs25 and Pvs28 despite antigenic polymorphism in field isolates. Sattabongkot J, Tsuboi T, Hisaeda H, Tachibana M, Suwanabun N, Rungruang T, Cao YM, Stowers AW, Sirichaisinthop J, Coleman RE, Torii M, Am J Trop Med Hyg 2003 69 536 541 14695092 (Pubitemid 38248256)
16. Plasmodium vivax ookinete surface protein Pvs25 linked to cholera toxin B subunit induces potent transmission-blocking immunity by intranasal as well as subcutaneous immunization. Miyata T, Harakuni T, Tsuboi T, Sattabongkot J, Kohama H, Tachibana M, Matsuzaki G, Torii M, Arakawa T, Infect Immun 2010 78 3773 3782 10.1128/IAI.00306-10 20584978
17. Intranasal and intramuscular immunization with Baculovirus Dual Expression System-based Pvs25 vaccine substantially blocks Plasmodium vivax transmission. Blagborough AM, Yoshida S, Sattabongkot J, Tsuboi T, Sinden RE, Vaccine 2010 28 6014 6020 10.1016/j.vaccine.2010.06.100 20637303
18. Immunogenicity in rhesus of the Plasmodium vivax mosquito stage antigen Pvs25H with Alhydrogel and Montanide ISA 720. Saul A, Hensmann M, Sattabongkot J, Collins WE, Barnwell JW, Langermans JA, Wu Y, Long CA, Dubovsky F, Thomas AW, Parasite Immunol 2007 29 525 533 10.1111/j.1365-3024.2007.00971.x 17883455 (Pubitemid 47460180)
19. Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malaria. Malkin EM, Durbin AP, Diemert DJ, Sattabongkot J, Wu Y, Miura K, Long CA, Lambert L, Miles AP, Wang J, Stowers A, Miller LH, Saul A, Vaccine 2005 23 3131 3138 10.1016/j.vaccine.2004.12.019 15837212
20. Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51. Wu Y, Ellis RD, Shaffer D, Fontes E, Malkin EM, Mahanty S, Fay MP, Narum D, Rausch K, Miles AP, Aebig J, Orcutt A, Muratova O, Song G, Lambert L, Zhu D, Miura K, Long C, Saul A, Miller LH, Durbin AP, PLoS One 2008 3 2636 10.1371/journal.pone.0002636 18612426
21. Sequence polymorphism in two novel Plasmodium vivax ookinete surface proteins, Pvs25 and Pvs28, that are malaria transmission-blocking vaccine candidates. Tsuboi T, Kaslow DC, Gozar MM, Tachibana M, Cao YM, Torii M, Mol Med 1998 4 772 782 9990863 (Pubitemid 29180124)
22. Sequence polymorphisms of Plasmodium vivax ookinete surface proteins (Pvs25 and Pvs28) from clinical isolates in Korea. Han ET, Lee WJ, Sattabongkot J, Jang JW, Nam MH, An SS, Suh I, Lim CS, Trop Med Int Health 2010 15 1072 1076
23. A monkey's tale: the origin of Plasmodium vivax as a human malaria parasite. Escalante AA, Cornejo OE, Freeland DE, Poe AC, Durrego E, Collins WE, Lal AA, Proc Natl Acad Sci USA 2005 102 1980 1985 10.1073/pnas.0409652102 15684081 (Pubitemid 40261998)
24. Genetic diversity of transmission blocking vaccine candidate (Pvs25 and Pvs28) antigen in Plasmodium vivax clinical isolates from Iran. Zakeri S, Razavi S, Djadid ND, Acta Trop 2009 109 176 180 10.1016/j.actatropica.2008.09.012 18950597
25. A rapid genotyping method for the vivax malaria transmission-blocking vaccine candidates, Pvs25 and Pvs28. Tsuboi T, Kaneko O, Cao YM, Tachibana M, Yoshihiro Y, Nagao T, Kanbara H, Torii M, Parasitol Int 2004 53 211 216 10.1016/j.parint.2004.01.012 15468527 (Pubitemid 38622622)
26. Antigenic repertoire of Plasmodium vivax transmission-blocking vaccine candidates from the Indian subcontinent. Prajapati SK, Joshi H, Dua VK, Malar J 2011 10 111 10.1186/1475-2875-10-111 21535892
27. Spatio-temporal distribution of malaria in Yunnan Province, China. Hui FM, Xu B, Chen ZW, Cheng X, Liang L, Huang HB, Fang LQ, Yang H, Zhou HN, Yang HL, Zhou XN, Cao WC, Gong P, Am J Trop Med Hyg 2009 81 503 509 19706922
28. History of the discovery of the malaria parasites and their vectors. Cox FE, Parasit Vectors 2010 3 5 10.1186/1756-3305-3-5 20205846
29. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Thompson JD, Higgins DG, Gibson TJ, Nucleic Acids Res 1994 22 4673 4680 10.1093/nar/22.22.4673 7984417 (Pubitemid 24354800)
30. DnaSP, DNA polymorphism analyses by the coalescent and other methods. Rozas J, Sanchez-DelBarrio JC, Messeguer X, Rozas R, Bioinformatics 2003 19 2496 2497 10.1093/bioinformatics/btg359 14668244 (Pubitemid 38016658)
31. Sequence variation of ookinete surface proteins Pvs25 and Pvs28 of Plasmodium vivax isolates from Southern Mexico and their association to local anophelines infectivity. Gonzalez-Ceron L, Alvarado-Delgado A, Martinez-Barnetche J, Rodriguez MH, Ovilla-Munoz M, Perez F, Hernandez-Avila JE, Sandoval MA, Rodriguez Mdel C, Villarreal-Trevino C, Infect Genet Evol 2010 10 645 654 10.1016/j.meegid.2010.03.014 20363376
32. Transmission-blocking vaccine candidate of Plasmodium vivax Pvs25 is highly conservative among Chinese isolates. Zheng L, Xu WM, Liu YJ, Yang YM, Cao YM, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 2004 22 16 19 15283259
33. Plasmodium vivax transmission: chances for control? Sattabongkot J, Tsuboi T, Zollner GE, Sirichaisinthop J, Cui L, Trends Parasitol 2004 20 192 198 10.1016/j.pt.2004.02.001 15099559 (Pubitemid 38526134)
34. Genetic polymorphism and natural selection in the malaria parasite Plasmodium falciparum. Escalante AA, Lal AA, Ayala FJ, Genetics 1998 149 189 202 9584096
35. Contrasting population structures of the genes encoding ten leading vaccine-candidate antigens of the human malaria parasite, Plasmodium falciparum. Barry AE, Schultz L, Buckee CO, Reeder JC, PLoS One 2009 4 8497 10.1371/journal.pone.0008497 20041125
36. Diversity and natural selection in Plasmodium vivax Duffy binding protein gene. Cole-Tobian J, King CL, Mol Biochem Parasitol 2003 127 121 132 10.1016/S0166-6851(02)00327-4 12672521 (Pubitemid 36369687)
37. Mosaic organization and heterogeneity in frequency of allelic recombination of the Plasmodium vivax merozoite surface protein-1 locus. Putaporntip C, Jongwutiwes S, Sakihama N, Ferreira MU, Kho WG, Kaneko A, Kanbara H, Hattori T, Tanabe K, Proc Natl Acad Sci USA 2002 99 16348 16353 10.1073/pnas.252348999 12466500 (Pubitemid 35462798)